Cargando…

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine

BACKGROUND & OBJECTIVES: Radioiodine ((131)I) or radioactive iodine in low doses is used worldwide as the first line of management in the treatment of hyperthyroidism. Information is available on the extent and severity of cell damage after a high dose radioiodine ((131)I) therapy for thyroid ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaram, P. Shanmuga, Padma, S., Sudha, S., Sasikala, K.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103173/
https://www.ncbi.nlm.nih.gov/pubmed/21537093